Intra-Cellular Therapies Inc. buy Royal Bank of Canada
Start price
03.04.24
/
50%
€62.50
Target price
03.04.25
€79.68
Performance (%)
2.40%
Price
14:08
€64.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 2.40%. This prediction currently runs until 03.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 1.587% | 1.587% |
iShares Core DAX® | -1.816% | -2.419% |
iShares Nasdaq 100 | 4.333% | 8.073% |
iShares Nikkei 225® | 0.657% | 1.234% |
iShares S&P 500 | 2.968% | 4.613% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $86.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.80
23.02.24
23.02.24
€79.43
23.02.25
23.02.25
-1.23%
14:08
14:08
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.60
31.01.24
31.01.24
€79.15
31.01.25
31.01.25
0.63%
14:08
14:08
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€51.40
03.11.23
03.11.23
€70.83
03.11.24
03.11.24
21.60%
14:08
14:08
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.50
04.08.23
04.08.23
€71.56
04.08.24
04.08.24
19.63%
14:08
14:08
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.00
02.03.23
02.03.23
€67.06
02.03.24
02.03.24
50.68%
03.03.24
03.03.24